AstraZeneca 1 post

• Recent developments in the diabetes landscape halfway into 2019
  1 September 2019  ·  AstraZeneca AZN Diabetes
  All manufacturers of anti-diabetic drugs have issued press releases on their Q2 earnings. Novo Nordisk on August 9th and Eli Lilly on July 30th . And the 79th Scientific Sessions of the American Diabetes Association took place June 7-11, so a look at the changes in the diabetes landscape is due.